The invention discloses a preparation method of
lung and mitochondria dual-targeting nanoparticles, which utilizes a
nanotechnology to efficiently load and accurately deliver an anti-inflammatory
drug, reduces the frequency and dosage of medication, and reduces the side effects of the
drug on patients. LSALTPSPSWLKYKAL is used for modifying lipidosome, and the LSA targeting
peptide competitively inhibits aggregation of
neutrophile granulocytes by being combined with a DPEP1
receptor, so that the effect of targeting the
lung to deliver drugs can be achieved, aggregation of
neutrophile granulocytes can be relieved, and
lung injury can be accurately treated. The lipidosome core layer wraps the
tannic acid cerium metal nanoparticles, not only has the
mitochondrial targeting characteristic of
tannic acid, but also can achieve the anti-oxidation effect through the change of the
cerium metal valence, thereby reducing the generation of mitochondrial
active oxygen, relieving the tissue
oxidative stress and protecting mitochondria. The
polyethylene glycol modified lipidosome can reduce the in-vivo
clearance rate of the lipidosome, prolong the half-life period of the
medicine and increase the compatibility with the body, and the
surface modification utilizes the characteristics of diseases to carry out controllable release and increase the availability of the
medicine. According to the invention, the progress of a
drug delivery technology is promoted, and a new thought and a technical platform are provided for
organelle targeted therapy.